Dirk‐Jan van den Berg

3.9k total citations · 1 hit paper
35 papers, 3.2k citations indexed

About

Dirk‐Jan van den Berg is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Dirk‐Jan van den Berg has authored 35 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 6 papers in Molecular Biology. Recurrent topics in Dirk‐Jan van den Berg's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Epilepsy research and treatment (5 papers). Dirk‐Jan van den Berg is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Epilepsy research and treatment (5 papers). Dirk‐Jan van den Berg collaborates with scholars based in Netherlands, United Kingdom and Germany. Dirk‐Jan van den Berg's co-authors include Aalt Bast, W. J. F. van der Vijgh, S.A.B.E. van Acker, W.P. van Bennekom, Elizabeth C. M. de Lange, Marcel J. de Groot, Georgette Plemper van Balen, J.A. Bouwstra, Suzanne M. Bal and Regina Lüttge and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Dirk‐Jan van den Berg

34 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural aspects of antioxidant activity of flavonoids

1996 1.1k citations S.A.B.E. van Acker, Dirk‐Jan van den Berg et al. Free Radical Biology and Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dirk‐Jan van den Berg Netherlands	19	939	650	640	622	480	35	3.2k
H.‐H. Sherry Chow United States	35	949 1.0×	1.2k 1.9×	251 0.4×	460 0.7×	176 0.4×	108	4.4k
Shuji Kitagawa Japan	32	183 0.2×	976 1.5×	231 0.4×	505 0.8×	437 0.9×	125	2.8k
Seon Hwa Lee South Korea	32	474 0.5×	1.8k 2.8×	523 0.8×	163 0.3×	110 0.2×	147	3.9k
Nicole H.P. Cnubben Netherlands	29	483 0.5×	1.2k 1.9×	238 0.4×	581 0.9×	91 0.2×	57	3.3k
Shing‐Chuan Shen Taiwan	39	390 0.4×	2.5k 3.8×	226 0.4×	502 0.8×	540 1.1×	90	4.9k
Erika Cione Italy	30	335 0.4×	1.2k 1.9×	197 0.3×	206 0.3×	131 0.3×	164	3.1k
Amal Kaddoumi United States	40	368 0.4×	1.2k 1.9×	519 0.8×	858 1.4×	234 0.5×	110	4.1k
Karla Slowing Spain	19	959 1.0×	2.3k 3.5×	452 0.7×	417 0.7×	140 0.3×	33	5.6k
Hyung Ryong Moon South Korea	37	343 0.4×	1.9k 2.8×	1.4k 2.1×	219 0.4×	323 0.7×	235	4.8k
P. Uma Devi India	29	149 0.2×	779 1.2×	164 0.3×	226 0.4×	165 0.3×	152	3.1k

Countries citing papers authored by Dirk‐Jan van den Berg

Since Specialization

Citations

This map shows the geographic impact of Dirk‐Jan van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk‐Jan van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk‐Jan van den Berg more than expected).

Fields of papers citing papers by Dirk‐Jan van den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk‐Jan van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk‐Jan van den Berg. The network helps show where Dirk‐Jan van den Berg may publish in the future.

Co-authorship network of co-authors of Dirk‐Jan van den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk‐Jan van den Berg. A scholar is included among the top collaborators of Dirk‐Jan van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk‐Jan van den Berg. Dirk‐Jan van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berg, Dirk‐Jan van den, et al.. (2024). CYP P450 and non-CYP P450 Drug Metabolizing Enzyme Families Exhibit Differential Sensitivities towards Proinflammatory Cytokine Modulation. Drug Metabolism and Disposition. 52(12). 1429–1437.

Wijk, Rob C. van, Dirk‐Jan van den Berg, Jeremy Liu, et al.. (2020). Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans. British Journal of Pharmacology. 177(24). 5518–5533. 11 indexed citations

Brink, W van den, Robin Hartman, Dirk‐Jan van den Berg, et al.. (2019). Blood‐Based Biomarkers of Quinpirole Pharmacology: Cluster‐Based PK/PD and Metabolomics to Unravel the Underlying Dynamics in Rat Plasma and Brain. CPT Pharmacometrics & Systems Pharmacology. 8(2). 107–117. 1 indexed citations

Kervezee, Laura, Robin Hartman, Dirk‐Jan van den Berg, Johanna H. Meijer, & Elizabeth C. M. de Lange. (2017). Diurnal variation in the pharmacokinetics and brain distribution of morphine and its major metabolite. European Journal of Pharmaceutical Sciences. 109. S132–S139. 23 indexed citations

Shimizu, Shinji, Sandra den Hoedt, Víctor Mangas‐Sanjuán, et al.. (2016). Target-Site Investigation for the Plasma Prolactin Response: Mechanism-Based Pharmacokinetic-Pharmacodynamic Analysis of Risperidone and Paliperidone in the Rat. Drug Metabolism and Disposition. 45(2). 152–159. 5 indexed citations

Yamamoto, Yumi, Pyry A. J. Välitalo, Dirk‐Jan van den Berg, et al.. (2016). A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations. Pharmaceutical Research. 34(2). 333–351. 55 indexed citations

Westerhout, Joost, Dirk‐Jan van den Berg, Robin Hartman, Meindert Danhof, & Elizabeth C. M. de Lange. (2014). Prediction of methotrexate CNS distribution in different species – Influence of disease conditions. European Journal of Pharmaceutical Sciences. 57. 11–24. 44 indexed citations

Kervezee, Laura, Robin Hartman, Dirk‐Jan van den Berg, et al.. (2014). Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain. The AAPS Journal. 16(5). 1029–1037. 47 indexed citations

Syvänen, Stina, Maarten Schenke, Dirk‐Jan van den Berg, Rob A. Voskuyl, & Elizabeth C. M. de Lange. (2012). Alteration in P-glycoprotein Functionality Affects Intrabrain Distribution of Quinidine More Than Brain Entry—A Study in Rats Subjected to Status Epilepticus by Kainate. The AAPS Journal. 14(1). 87–96. 17 indexed citations

10.

Stevens, Jasper, et al.. (2010). Online solid phase extraction with liquid chromatography–tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples. Journal of Chromatography B. 878(13-14). 969–975. 16 indexed citations

11.

Ding, Zhi, Maytal Bivas‐Benita, Laura Bungener, et al.. (2009). Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. Journal of Controlled Release. 136(1). 71–78. 117 indexed citations

12.

Bal, Suzanne M., Dirk‐Jan van den Berg, Martin van Hecke, et al.. (2008). Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. Journal of Controlled Release. 128(1). 80–88. 188 indexed citations

13.

Wutzke, Klaus D., Dirk‐Jan van den Berg, & Dieter Haffner. (2007). The metabolic fate of doubly stable isotope labelled heat-killed Lactobacillus johnsonii in humans. European Journal of Clinical Nutrition. 62(2). 197–202. 2 indexed citations

14.

Acker, S.A.B.E. van, Georgette Plemper van Balen, Dirk‐Jan van den Berg, Aalt Bast, & W. J. F. van der Vijgh. (1998). Influence of iron chelation on the antioxidant activity of flavonoids. Biochemical Pharmacology. 56(8). 935–943. 243 indexed citations

15.

Hoffmann‐Fezer, G., Wolfgang Beisker, Dirk‐Jan van den Berg, et al.. (1997). Preclinical evaluation of biotin labeling for red cell survival testing. Annals of Hematology. 74(5). 231–238. 16 indexed citations

16.

Acker, S.A.B.E. van, et al.. (1996). Structural aspects of antioxidant activity of flavonoids. Free Radical Biology and Medicine. 20(3). 331–342. 1105 indexed citations breakdown →

17.

Kramer, Klaas, S.A.B.E. van Acker, Joop A. Grimbergen, et al.. (1995). Effect of dimethyl sulfoxide (DMSO) on the electrocardiogram (ECG) in freely moving male Balb/c mice. General Pharmacology The Vascular System. 26(6). 1403–1407. 18 indexed citations

18.

Kramer, Klaas, et al.. (1995). Monohydroxyethylrutoside as protector against chronic doxorubicin‐induced cardiotoxicity. British Journal of Pharmacology. 115(7). 1260–1264. 47 indexed citations

19.

Wischnik, A., et al.. (1983). [Magnesium aspartate as a cardioprotective agent and adjuvant in tocolysis with betamimetics. Animal experiments on the kinetics and calcium antagonist action of orally administered magnesium aspartate with special reference to simultaneous vitamin B administration].. PubMed. 186(6). 326–34. 1 indexed citations

20.

Jungck, Edwin C., et al.. (1981). Mixture of bupivacaine 0.5% and hyperbaric mepivacaine 4% for spinal anaesthesia.. PubMed. 30(10). 63–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact